{
    "2018-12-06": [
        [
            {
                "time": "2018-12-06",
                "original_text": "沪港通十大成交活跃股排名（12月6日）",
                "features": {
                    "keywords": [
                        "沪港通",
                        "成交活跃",
                        "医药股"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-07",
                "original_text": "带量采购发威，A、H医药股一日蒸发超千亿市值！这些药企已有对策，有股票直线拉涨 连续下跌",
                "features": {
                    "keywords": [
                        "带量采购",
                        "医药股",
                        "市值蒸发",
                        "对策"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-07",
                "original_text": "收评：沪指跌逾1%险守2600点 医药股午后大跌",
                "features": {
                    "keywords": [
                        "沪指",
                        "医药股",
                        "大跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-07",
                "original_text": "医药板块遭遇重挫：带量采购预中选出炉(附公司名单)",
                "features": {
                    "keywords": [
                        "医药板块",
                        "带量采购",
                        "重挫"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-07",
                "original_text": "仿制药概念午后急速下挫 乐普医疗跌停",
                "features": {
                    "keywords": [
                        "仿制药",
                        "乐普医疗",
                        "跌停"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-07",
                "original_text": "恒瑞医药午后异动重挫5.69%报63.10元 成交7.2亿元",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "异动",
                        "重挫"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-07",
                "original_text": "一致性评价+带量采购=压力山大！2019年药企不能再走寻常路",
                "features": {
                    "keywords": [
                        "一致性评价",
                        "带量采购",
                        "压力"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}